Karen W. Jeng-Miller, MD, MPH | Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts Eric D. Gaier, MD, PhD | Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts Angela V. Turalba, MD | Department of Ophthalmology, Atrius Health, Boston, Massachusetts
In the Emergency Ward, latanoprost 0.005%, dorzolamide/timolol 22.3-6.8 mg/mL, and brimonidine 0.1% were administered in both eyes; the patient was given 500 mg oral acetazolamide to lower the IOP. Atropine 1% was also administered in both eyes. His IOP decreased to 37 mm Hg in each eye. Medications were maintained for 24 hours; IOP decreased to 15 mm Hg in each eye by the following day. His uncorrected visual acuity returned to his baseline of 20/20 in each eye by day 3, with improvement of his anterior chamber depth on biometry to 3.54 mm in the right eye and 3.56 mm in the left eye as measured by LENSTAR LS 900 Biometer. He was tapered off all drops and oral medications within 1 week. Serial UBM images showed resolution of the uveal effusions (Figure 2B). Automated static perimetry indicated no glaucomatous defects.